MGNX Next Earnings Date Notes

— MacroGenics (MGNX) is a clinical-stage biopharmaceutical company specializing in the discovery & development of innovative antibody-based therapeutics for the treatment of cancer. The company leverages its proprietary Fc Optimization & DART™ (Dual-Affinity Re-Targeting) platforms to create novel immunotherapies designed to enhance anti-tumor immunity. MacroGenics’ pipeline includes several wholly-owned assets and partnered programs, with key clinical candidates such as vobra duo (an ADC for breast cancer) & flotetuzumab (a bispecific T-cell engager for acute myeloid leukemia). For investors, the most relevant business metrics to watch on earnings calls include: cash runway & balance (reflecting MGNX’s ability to fund clinical operations), clinical trial enrollment updates and data readouts (which show pipeline progress & likelihood of future approvals), revenue from collaboration & license agreements, research & development (R&D) spend, and near-term regulatory milestones. Listening for management commentary on partnerships with larger pharma companies or updates on collaborations can provide insight into external validation & future non-dilutive funding potential, both of which are crucial for a development-stage company’s long-term success. The next projected earnings date for MGNX is 5/12/2026 after close (stay tuned for a confirmed earnings date once announced).

MGNX Next Earnings Date FAQ

On this page we presented the MGNX Next Earnings Date information for Macrogenics along with recent past earnings dates. For Q4 of 2025, MGNX reported earnings of -0.220/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, MGNX reported earnings of 0.270/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, MGNX reported earnings of -0.570/share, with the earnings report taking place on 8/14/2025. For Q1 of 2025, MGNX reported earnings of -0.650/share, with the earnings report taking place on 5/13/2025. For Q4 of 2024, MGNX reported earnings of -0.250/share, with the earnings report taking place on 3/20/2025. Based on these past earnings dates, the projected next earnings date for MGNX is 5/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Macrogenics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Macrogenics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Macrogenics next earnings dates as well as any other stock out there in our coverage universe, to see when the next MGNX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up MGNX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the MGNX next earnings date.